Biblio

Author [ Title(Desc)] Type Year
Filters: Author is Tan, Patrick  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
Xiong L, Wu F, Wu Q, Xu L, Cheung OK, Kang W, Mok MT, Szeto LLM, Lun C-Y, Lung RW, et al. Aberrant enhancer hypomethylation contributes to hepatic carcinogenesis through global transcriptional reprogramming. Nat Commun. 2019;10(1):335.
Li W, Okabe A, Usui G, Fukuyo M, Matsusaka K, Rahmutulla B, Mano Y, Hoshii T, Funata S, Hiura N, et al. Activation of EHF via STAT3 phosphorylation by LMP2A in Epstein-Barr virus-positive gastric cancer. Cancer Sci. 2021.
Chan SHoai, Bylstra Y, Teo JXian, Kuan JLing, Bertin N, Gonzalez-Porta M, Hebrard M, Tirado-Magallanes R, Tan JHui Juan, Jeyakani J, et al. Analysis of clinically relevant variants from ancestrally diverse Asian genomes. Nat Commun. 2022;13(1):6694.
C
Choo J, Kua LFang, Soe MYar, Asuncion BReyna, Tan BKye Jyn, Teo CBoon, Tay RYong Kiat, So J, Shabbir A, Guowei K, et al. Clinical relevance of PD-1 positive CD8 T-cells in gastric cancer. Gastric Cancer. 2023.
Leontovyč R, Young ND, Korhonen PK, Hall RS, Tan P, Mikeš L, Kašný M, Horák P, Gasser RB. Comparative Transcriptomic Exploration Reveals Unique Molecular Adaptations of Neuropathogenic Trichobilharzia to Invade and Parasitize Its Avian Definitive Host. PLoS Negl Trop Dis. 2016;10(2):e0004406.
Xu C, Huang KKyon, Law JHao, Chua JShijia, Sheng T, Flores NM, Pizzi MPool, Okabe A, Tan ALay Keng, Zhu F, et al. Comprehensive molecular phenotyping of -deficient gastric cancer reveals pervasive epigenomic reprogramming and therapeutic opportunities. Gut. 2023.
Fan Q, Li H, Wang X, Tham Y-C, Teo KYi Chong, Yasuda M, Lim WKhong, Kwan YPing, Teo JXian, Chen C-J, et al. Contribution of common and rare variants to Asian neovascular age-related macular degeneration subtypes. Nat Commun. 2023;14(1):5574.
Izumi D, Ishimoto T, Miyake K, Sugihara H, Eto K, Sawayama H, Yasuda T, Kiyozumi Y, Kaida T, Kurashige J, et al. CXCL12/CXCR4 Activation by Cancer-Associated Fibroblasts Promotes Integrin ß1 Clustering and Invasiveness in Gastric Cancer. Int J Cancer. 2015.
D
Tan J, Tan P, Teh BTean. Defining the Molecular Alterations of Ampullary Carcinoma. Cancer Cell. 2016;29(2):135-136.
Ho SWei Ting, Tan P. Dissection of Gastric Cancer Heterogeneity for Precision Oncology. Cancer Sci. 2019.
E
Mizokami H, Okabe A, Choudhary R, Mima M, Saeda K, Fukuyo M, Rahmutulla B, Seki M, Goh B-C, Kondo S, et al. Enhancer infestation drives tumorigenic activation of inactive B compartment in Epstein-Barr virus-positive nasopharyngeal carcinoma. EBioMedicine. 2024;102:105057.
Lim WKhong, Ong CKiat, Tan J, Thike AAye, Ng CChuan Youn, Rajasegaran V, Myint SSwe, Nagarajan S, Nasir NDiyana Md, McPherson JR, et al. Exome sequencing identifies highly recurrent MED12 somatic mutations in breast fibroadenoma. Nat Genet. 2014.
Cutcutache I, Suzuki Y, Tan IBeehuat, Ramgopal S, Zhang S, Ramnarayanan K, Gan A, Lee HHong, Tay STing, Ooi A, et al. Exome-wide Sequencing Shows Low Mutation Rates and Identifies Novel Mutated Genes in Seminomas. Eur Urol. 2015.
F
Silva ANS, Coffa J, Menon V, Hewitt LC, Das K, Miyagi Y, Bottomley D, Slaney H, Aoyama T, Mueller W, et al. Frequent Coamplification of Receptor Tyrosine Kinase and Downstream Signaling Genes in Japanese Primary Gastric Cancer and Conversion in Matched Lymph Node Metastasis. Ann Surg. 2016.
G
Xing M, Ooi WFong, Tan J, Qamra A, Lee P-H, Li Z, Xu C, Padmanabhan N, Lim JQuan, Guo YAmanda, et al. Genomic and epigenomic EBF1 alterations modulate TERT expression in gastric cancer. J Clin Invest. 2020.
Tan J, Ong CKiat, Lim WKhong, Ng CChuan Youn, Thike AAye, Ng LMoy, Rajasegaran V, Myint SSwe, Nagarajan S, Thangaraju S, et al. Genomic landscapes of breast fibroepithelial tumors. Nat Genet. 2015.
Toh MRen, Chiang JBang, Chong STing, Chan SHoai, Ishak NDiana Bint, Courtney E, Lee WHao, Al SMuhammad F, Allen JCarson, Lim KHon, et al. Germline Pathogenic Variants in Homologous Recombination and DNA Repair Genes in an Asian Cohort of Young-Onset Colorectal Cancer. JNCI Cancer Spectr. 2018;2(4):pky054.
Kuderna LFK, Gao H, Janiak MC, Kuhlwilm M, Orkin JD, Bataillon T, Manu S, Valenzuela A, Bergman J, Rousselle M, et al. A global catalog of whole-genome diversity from 233 primate species. Science. 2023;380(6648):906-913.
H
Tham C-Y, Poon LF, Yan T, Koh JYu Peng, Ramlee MKhairul, Teoh VSwee Imm, Zhang S, Cai Y, Hong Z, Lee GS, et al. High-throughput telomere length measurement at nucleotide resolution using the PacBio high fidelity sequencing platform. Nat Commun. 2023;14(1):281.
I
Kuderna LFK, Ulirsch JC, Rashid S, Ameen M, Sundaram L, Hickey G, Cox AJ, Gao H, Kumar A, Aguet F, et al. Identification of constrained sequence elements across 239 primate genomes. Nature. 2023.
Yasuda T, Koiwa M, Yonemura A, Miyake K, Kariya R, Kubota S, Yokomizo-Nakano T, Yasuda-Yoshihara N, Uchihara T, Itoyama R, et al. Inflammation-driven senescence-associated secretory phenotype in cancer-associated fibroblasts enhances peritoneal dissemination. Cell Rep. 2021;34(8):108779.
Usui G, Matsusaka K, Huang KKyon, Zhu F, Shinozaki T, Fukuyo M, Rahmutulla B, Yogi N, Okada T, Minami M, et al. Integrated environmental, lifestyle, and epigenetic risk prediction of primary gastric neoplasia using the longitudinally monitored cohorts. EBioMedicine. 2023;98:104844.
Ooi WFong, Nargund AM, Lim KJunliang, Zhang S, Xing M, Mandoli A, Lim JQuan, Ho SWei Ting, Guo Y, Yao X, et al. Integrated paired-end enhancer profiling and whole-genome sequencing reveals recurrent and enhancer hijacking in primary gastric adenocarcinoma. Gut. 2019.
Gwee YXiang, Chia DKai Ann, So J, Ceelen W, Yong WPeng, Tan P, Ong C-AJohnny, Sundar R. Integration of Genomic Biology Into Therapeutic Strategies of Gastric Cancer Peritoneal Metastasis. J Clin Oncol. 2022:JCO2102745.
Hong JHan, Yong CHan, Heng HLee, Chan JYongsheng, Lau MChan, Chen J, Lee JYi, Lim AHerbert, Li Z, Guan P, et al. Integrative multiomics enhancer activity profiling identifies therapeutic vulnerabilities in cholangiocarcinoma of different etiologies. Gut. 2023.

Pages